Delivering Exceptional Outcome
Applied Biologics™ is the global leader in developing and supporting research using amnion-derived technology. Given its rich source of multipotential cells, growth factors, hyaluronic acid, proteins and the unique immune privilege that characterizes human amnion function in the body, Applied Biologics™ is focused on optimizing the regenerative potential of this unique allograft. Since 2010, Applied Biologics™ has been the nation's leader in providing superior amnion technology for orthopedic defects, chronic wounds, and nerve, ligament and tendon repair.
AmnioGenic TherapyTM - Developed and delivered exclusively by Applied Biologics™
Our cadaveric allograft resources are processed and packaged at an FDA-registered tissue bank. Those allografts derived from live donors are also processed and packaged at an FDA registered tissue bank in accordance with cGTP standards and are regulated by the FDA under 21 CFR Part 1271 and Section 361 of the Public Health Service Act.
Amnion & Base Tissue
AmnioGenic TherapyTM, delivered exclusively by Applied Biologics™, addresses a broad spectrum of clinical applications and specialties:
- Soft-Tissue Defects
- Localized Points of Inflammation
- Tendon, Ligament, Nerve Covering
- Fibroblast Reduction
- Sports Injury & Orthopedics
- General Surgery & Trauma
- Chronic Wound Management
- Urology & OB/GYN
The Applied Biologics™ executive team and our professional sales force consists mainly of former military and medically trained professionals. All of our sales representatives are professional, responsive and knowledgeable. Our client's products are represented accurately and faithfully to our customer base of hospitals, doctors and caregivers.